ARCTURUS THERAPEUTICS HLDGS's ticker is ARCT and the CUSIP is 03969T109. A total of 149 filers reported holding ARCTURUS THERAPEUTICS HLDGS in Q3 2023. The put-call ratio across all filers is 1.01 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,737,835 | +344.5% | 107,156 | +157.8% | 0.02% | +320.0% |
| Q3 2022 | $616,000 | -92.1% | 41,567 | -91.7% | 0.01% | -93.4% |
| Q2 2022 | $7,840,000 | +282.1% | 498,097 | +554.6% | 0.08% | +322.2% |
| Q1 2022 | $2,052,000 | -83.2% | 76,096 | -77.0% | 0.02% | -83.8% |
| Q4 2021 | $12,241,000 | +70.1% | 330,748 | +119.6% | 0.11% | +48.0% |
| Q3 2021 | $7,197,000 | +804.1% | 150,627 | +540.1% | 0.08% | +837.5% |
| Q2 2021 | $796,000 | +0.4% | 23,532 | +22.5% | 0.01% | -20.0% |
| Q1 2021 | $793,000 | -48.2% | 19,208 | -45.5% | 0.01% | -52.4% |
| Q4 2020 | $1,530,000 | -83.4% | 35,268 | -83.5% | 0.02% | -88.0% |
| Q3 2020 | $9,196,000 | +406.4% | 214,370 | +451.4% | 0.18% | +629.2% |
| Q2 2020 | $1,816,000 | – | 38,874 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tri Locum Partners LP | 208,886 | $5,337,037 | 1.71% |
| Portolan Capital Management | 276,505 | $7,064,703 | 0.66% |
| Nikko Asset Management Americas, Inc. | 1,388,574 | $35,422,523 | 0.42% |
| Green Alpha Advisors, LLC | 21,538 | $550,296 | 0.42% |
| SummerHaven Investment Management, LLC | 22,326 | $570,429 | 0.42% |
| ARK Investment Management | 1,901,546 | $48,584,508 | 0.37% |
| Granahan Investment Management | 398,862 | $10,190,924 | 0.36% |
| FEDERATED HERMES, INC. | 4,711,512 | $120,379,132 | 0.32% |
| Woodline Partners LP | 1,069,814 | $27,333,748 | 0.32% |
| Diametric Capital, LP | 26,130 | $667,621 | 0.28% |